JP Morgan Maintains Overweight on ArcBest, Lowers Price Target to $145
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Brian Ossenbeck has maintained an Overweight rating on ArcBest (NASDAQ:ARCB) but lowered the price target from $164 to $145.

May 01, 2024 | 3:10 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
JP Morgan has maintained its Overweight rating on ArcBest but reduced the price target from $164 to $145.
The reduction in price target by JP Morgan, a major financial institution, could lead to a negative short-term sentiment among investors, potentially causing a decrease in ArcBest's stock price. The Overweight rating indicates a positive outlook on the stock, but the lowered price target suggests adjustments in valuation expectations, which might be due to revised earnings forecasts or market conditions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100